Suchergebnisse - "Ma, Hong-Hao"

PubPharm (4)

1

Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in children

enthalten in: British journal of haematology | 2023

von Zhang, Q. | Zhou, C. | Li, D. | +10

2

A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

enthalten in: Blood | 2022

von Zhang, Q. | Zhao, Y. | Ma, H. | +8

CommentIn: Blood. 2022 Jun 16;139(24):3453-3455. - PMID 35708727

3

Development and application of an LC-MS/MS method for pharmacokinetic study of ruxolitinib in children with hemophagocytic lymphohistiocytosis

enthalten in: Analytical methods : advancing methods and applications | 2022

von Li, Z. | Sun, N. | Zhang, Q. | +6

4

A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis

enthalten in: Haematologica | 2021

von Zhang, Q. | Wei, A. | Ma, H. | +10

1
[1]